Skip to main content
. 2021 May 18;9(6):e793–e801. doi: 10.1016/S2214-109X(21)00105-4

Table 3.

Percentage point change in the proportion of women in need of contraception and the proportion of women using contraception among those in need before and during COVID-19

Burkina Faso
Kinshasa, Democratic Republic of the Congo
Kenya
Lagos, Nigeria
Urban
Rural
Urban
Urban
Rural
Urban
Change 95% CI Change 95% CI Change 95% CI Change 95% CI Change 95% CI Change 95% CI
Total sample
In need 0·34 −3·64 to 4·32 1·27 −4·43 to 6·98 2·67 −3·85 to 9·18 3·48 −0·76 to 7·72 0·06 −2·74 to 2·87 5·81 1·29 to 10·34
Contraceptive use 2·79 −2·11 to 7·69 17·37 7·87 to 26·87 0·20 −8·03 to 7·63 5·24 1·21 to 9·27 7·35 5·10 to 9·59 −0·95 −8·33 to 6·43
Age
Youngest (<25 years)
In need 6·05 −1·50 to 13·61 6·69 −8·48 to 21·87 14·02 −7·28 to 35·33 5·05 −4·15 to 14·25 6·62 −7·60 to 20·83 23·58 3·13 to 50·29
Contraceptive use 6·14 −4·71 to 16·99 19·94 4·63 to 35·25 3·60 −21·36 to 28·57 3·90 −5·50 to 13·30 7·06 −0·46 to 13·67 −24·35 −56·54 to 7·85
Middle (25–34 years)
In need 0·12 −5·02 to 5·26 −4·60 −13·76 to 4·55 0·32 −8·82 to 9·46 2·91 −2·61 to 8·43 0·99 −2·85 to 4·83 9·95 1·56 to 18·34
Contraceptive use −1·32 −7·75 to 5·10 18·54 5·84 to 31·23 −4·61 −14·71 to 5·49 3·74 −1·38 to 8·86 4·73 −0·41 to 9·87 −2·36 −13·77 to 9·05
Oldest (≥35 years)
In need −2·49 −8·69 to 3·70 4·28 −5·23 to 13·79 2·64 −6·30 to 11·59 3·47 −2·86 to 9·81 −3·48 −7·35 to 0·39 2·13 −3·82 to 8·08
Contraceptive use 5·96 −2·55 to 14·47 15·05 1·58 to 28·52 3·24 −7·88 to 14·35 7·96 1·10 to 14·81 9·50 3·35 to 15·65 0·88 −9·18 to 10·94
Parity
Nulliparous (parity=0)
In need 23·34 13·55 to 33·13 38·88 21·59 to 56·18 28·84 8·33 to 49·35 35·27 16·42 to 54·12 35·07 18·89 to 51·24 26·19 10·17 to 42·21
Contraceptive use 26·30 1·26 to 51·35 −3·59 −63·85 to 56·67 −25·21 −77·13 to 26·70 2·09 −25·01 to 29·18 45·33 17·95 to 72·70 .. ..
Low parity (1–2 children)
In need −0·51 −6·34 to 5·31 1·56 −11·02 to 14·14 1·48 −8·13 to 11·09 0·80 −4·52 to 6·12 2·46 −2·61 to 7·53 6·82 −2·98 to 16·61
Contraceptive use 2·01 −4·86 to 8·89 18·99 3·73 to 34·24 0·60 −11·96 to 13·17 5·38 −0·09 to 10·84 6·24 0·80 to 11·68 −2·08 −13·81 to 9·65
Higher parity (≥3 children)
In need −2·54 −7·58 to 2·50 −1·49 −8·14 to 5·17 0·11 −8·20 to 8·42 1·90 −3·57 to 7·38 −2·70 −5·52 to 0·11 3·21 −1·23 to 7·65
Contraceptive use 4·49 −1·88 to 10·86 18·00 7·80 to 28·21 1·96 −7·50 to 11·43 6·71 0·74 to 12·68 7·53 3·07 to 11·99 0·49 −9·22 to 10·21
Education
Lower education (less than secondary)
In need −1·72 −6·80 to 3·35 1·26 −4·75 to 7·28 12·60 −11·35 to 36·54 1·79 −4·36 to 7·93 −1·84 −5·21 to 1·54 3·84 −9·55 to 17·23
Contraceptive use 2·18 −4·13 to 8·49 17·83 7·98 to 27·69 −8·12 −32·17 to 15·94 5·89 −0·04 to 11·74 7·30 2·48 to 12·12 7·44 −13·63 to 28·51
Higher education (secondary or more)
In need 3·99 −1·76 to 9·74 1·39 −15·37 to 18·15 1·46 −4·85 to 7·77 4·67 −0·52 to 9·86 3·53 −0·59 to 7·66 6·17 1·27 to 11·07
Contraceptive use 3·60 −2·39 to 9·59 9·16 −16·51 to 34·84 1·05 −7·22 to 9·33 4·74 −0·48 to 9·96 7·26 2·48 to 12·04 −2·69 −10·10 to 4·72
Wealth
Lowest tertile
In need 17·19 −14·63 to 49·02 2·89 −6·88 to 12·65 −3·74 −15·78 to 8·30 2·86 −14·60 to 20·33 −1·70 −5·72 to 2·32 3·95 −4·74 to 12·63
Contraceptive use 2·51 −26·33 to 31·36 22·16 7·66 to 36·66 −4·04 −20·26 to 12·18 10·98 −1·40 to 23·35 9·04 3·48 to 14·60 −2·89 −15·91 to 10·14
Middle tertile
In need −1·57 −17·20 to 14·06 −1·53 −10·30 to 7·23 12·20 0·32 to 24·73 2·14 −5·28 to 9·56 0·92 −2·71 to 4·55 6·98 −2·02 to 15·98
Contraceptive use 1·41 −17·75 to 20·57 13·94 0·54 to 27·35 4·12 −8·20 to 16·43 6·51 0·01 to 13·02 5·88 1·09 to 10·67 0·56 −12·51 to 13·64
Highest tertile
In need −0·03 −3·97 to 3·90 5·51 −6·11 to 17·14 0·16 −7·59 to 7·90 4·14 −0·69 to 8·97 3·99 −2·51 to 10·49 6·40 −1·30 to 14·09
Contraceptive use 2·88 −2·19 to 7·96 12·09 −7·85 to 32·02 −0·45 −12·83 to 11·93 3·74 −5·90 to 13·37 4·88 −2·06 to 11·83 −0·58 −11·12 to 9·95
Economic loss related to COVID-19
None
In need 2·68 −6·42 to 11·79 1·11 −9·54 to 11·77 −9·28 −29·30 to 10·74 10·69 −4·87 to 26·25 −3·87 −14·34 to 6·59 −10·92 −37·24 to 15·40
Contraceptive use 3·96 −4·97 to 12·89 14·41 −0·54 to 29·36 16·75 −10·57 to 44·07 2·66 −12·66 to 17·98 9·88 0·40 to 19·37 10·96 −22·66 to 44·58
Partial
In need −1·41 −5·75 to 2·92 2·86 −4·19 to 9·90 7·11 −4·84 to 19·06 2·40 −2·64 to 7·44 −0·05 −3·61 to 3·52 10·48 3·87 to 17·09
Contraceptive use 2·67 −3·58 to 8·91 20·66 10·62 to 30·70 −10·23 −24·19 to 3·74 6·00 0·94 to 11·05 6·04 1·11 to 10·96 −2·39 −11·96 to 7·18
Complete
In need 4·98 −3·45 to 13·40 −3·59 −19·07 to 11·88 1·89 −6·52 to 10·31 4·02 −2·43 to 10·47 0·79 −2·94 to 4·52 0·24 −8·05 to 8·53
Contraceptive use 1·90 −10·44 to 14·23 9·88 −11·66 to 31·42 1·95 −7·25 to 11·14 4·54 −1·77 to 10·84 8·45 3·17 to 13·72 −0·25 −12·62 to 12·13

An inadequate sample size of nulliparous women in need of contraception in Lagos prohibited analysis of contraceptive use.